Literature DB >> 17111030

Are there ventricle-specific postnatal maturational differences in myocardial beta-adrenoceptors?

Carin Wittnich1, Michael P Belanger, Karim Bandali.   

Abstract

Newborn hearts have restricted functional reserve and variable responsiveness to inotropes that could be partly due to differences in myocardial beta-adrenoceptors (beta-AR). To clarify this issue, this study documented ventricle-specific changes in myocardial beta-AR density and affinity during postnatal maturation. In vivo left and right ventricle (LV and RV, respectively) biopsies were obtained from newborn (3-day-old, n = 11), immature (14-day-old, n = 7), and adult (n = 6) pigs. Total beta-AR density (B(max), fmol/g) and dissociation constant (K(d), pmol/L) were determined by radioligand binding with I125 iodocyanopindolol. Overall, beta-AR B(max) in the LV significantly decreased with maturation. Interestingly, newborn animal hearts (LV and RV) subdivided into 2 groups: an adult-like low K(d) group with low B(max) and a fetal-like high K(d) group with high B(max), which were significantly different from one another. The high K(d) newborn group also had significantly higher K(d) and B(max) than both immature and adult hearts. Newborns had similar Bmax but higher Kd in the LV than the RV, whereas immature and adult hearts did not have ventricular differences. During maturation, beta-AR density decreased, whereas LV beta-AR binding affinity increased. Variable beta-AR maturity was also identified immediately post partum, which could potentially explain the newborn heart's variable responsiveness to inotropes. The subset of newborn hearts with lower binding affinity (reduced responsiveness) could also contribute to the newborn heart's overall reduction in functional reserve.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111030     DOI: 10.1139/y06-026

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  2 in total

1.  Age- and chamber-specific differences in oxidative stress after ischemic injury.

Authors:  E Bernadette Cabigas; Guoliang Ding; Tao Chen; Talib B Saafir; Karl D Pendergrass; Mary B Wagner; Michael E Davis
Journal:  Pediatr Cardiol       Date:  2011-11-06       Impact factor: 1.655

2.  Role of β-blocker therapy in pediatric heart failure.

Authors:  Akash R Patel; Robert E Shaddy
Journal:  Ped Health       Date:  2010
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.